KpKP13 Protein target profile

Phospholipase A1 bifunctional protein

Accession: KP13_01718

Gene: pldA AHE46978.1 3D evidence: AlphaFold DB model + ColabFold model UniProt A0A0H3GGK3
Length 286
Pocket druggability (P2Rank · AlphaFold DB model) 0.909
Direct ligand evidence 0 51 total records
Functional annotation 2 EC 8 GO
Target summary

Promising target candidate with multiple supporting evidence streams.

Automated synthesis of the evidence currently loaded. Review the underlying records before prioritizing this protein.

Terms and data sources used on this page

PDB: experimentally determined structures from the Protein Data Bank. These are the strongest structural evidence, but may cover only part of the protein.

AlphaFold DB model: a precomputed predicted structure downloaded from AlphaFold Database/UniProt, not an experiment performed here.

ColabFold model: a predicted structure generated for this workspace; interpret it with coverage and confidence.

pLDDT: confidence score for predicted structures. High values support local geometry; low values mean the region should not drive pocket interpretation.

FPocket / P2Rank: software tools that predict possible ligand-binding pockets on a 3D structure. They are useful screening signals, not experimental validation.

Druggability: a pocket-based estimate of whether a small molecule could bind productively. It does not mean a drug already exists.

PDB ligand: a compound observed in an experimental structure. Direct same-protein records are stronger than homolog-transferred records.

ChEMBL: a public database of measured compound bioactivity. Direct entries are stronger than entries transferred from similar proteins.

ZINC: a purchasable-compound database. Here it marks proposed candidates from chemical similarity, not measured binders.

LigQ / LigQ_2: an internal Target pipeline step that gathers PDB, ChEMBL, and ZINC ligand evidence for each protein.

Off-target: sequence similarity to proteins we prefer not to hit, such as human proteins or beneficial gut microbiome proteins.

DEG: Database of Essential Genes. A match suggests the protein resembles genes known to be essential in other organisms.

Roary / CoreCruncher: pan-genome tools used to decide whether a gene is core across analyzed strains or accessory/strain-specific.

EC / GO: functional annotations: EC describes enzyme reactions; GO describes biological process, molecular function, or cellular component.

KEGG pathway: a curated metabolic route label used here to group reactions imported from the metabolic model.

Chokepoint: a metabolic reaction that is the only producer or consumer of a metabolite in the imported model.

Prioritization evidence

Selectivity, essentiality, structural confidence, conservation, and predicted binding-site evidence.

Off-target risk

Human off-target
No hit
Gut microbiome similarity
2.2% of screened genomes Lower prevalence suggests narrower overlap with the screened gut microbiome.

Essentiality

Essential (DEG)
N
DEG identity (%)
0.0 Higher values support similarity to known essential genes.

Structure confidence

ColabFold pLDDT
92.34 0-100 confidence; >70 supports local structural interpretation.

Binding-site evidence

AlphaFold DB / UniProt model

P2Rank's binding-site probability is the primary druggability signal shown across the app; FPocket's druggability score is shown alongside it for comparison. Both estimate small-molecule pocket quality after applying the curated structure priority — neither is experimental binding evidence. The 3D viewer may show a different loaded structure, so visible pockets can differ.

Druggability (P2Rank) 0.909
Structure A0A0H3GGK3
Pocket Pocket 1
Druggability (FPocket) 0.67
Structure A0A0H3GGK3
Pocket Pocket 8
ColabFold model
P2Rank 0.903 · Pocket 1
FPocket 0.974 · Pocket 25
Core conservation Conserved core gene
Roary core
CoreCruncher core
Gut microbiome 104 / 4744 genomes with a hit
Prevalence 2.2%

Sequence

Primary amino-acid sequence viewer.

MRISLACLVALCALPAGVMAQDASVHDKPAVRGSIIANLLQDHDNPFLLYPYESNYLLYTWTSDLNKEAIRSYDWAENARKDEVKFQLSLAFPLWRGILGDNSLLGASYTQKSWWQLSNSKESAPFRETNYEPQLFLGFATDYQFAGWTLRDIEMGYNHDSNGRSDPTSRSWNRLYARLMAQNGNWLVEVKPWYVVGNTDDNPDITKYMGYYRLKVGYQLGEAILSAQGQYNWNTGYGGAELGVSYPITKHVRAYTQIYSGYGESLIDYNFNQTRVGVGLMLNDLF

Functional annotations

Enzyme classification and Gene Ontology terms linked to this protein.

2 EC 8 GO

Subcellular localization

Localization
OuterMembrane

Enzyme Commission (EC)

2

Gene Ontology (GO)

8
  • GO:0004620 Catalysis of the hydrolysis of a glycerophospholipid.
  • GO:0016020 A lipid bilayer along with all the proteins and protein complexes embedded in it and attached to it.
  • GO:0006629 The chemical reactions and pathways involving lipids, compounds soluble in an organic solvent but not, or sparingly, in an aqueous solvent. Includes fatty acids; neutral fats, other fatty-acid esters, and soaps; long-chain (fatty) alcohols and waxes; sphingoids and other long-chain bases; glycolipids, phospholipids and sphingolipids; and carotenes, polyprenols, sterols, terpenes and other isoprenoids.
  • GO:0009279 A lipid bilayer that forms the outermost membrane of the cell envelope; enriched in polysaccharide and protein; the outer leaflet of the membrane contains specific lipopolysaccharide structures.
  • GO:0005509 Binding to a calcium ion (Ca2+).
  • GO:0008970 Catalysis of the reaction: a 1,2-diacyl-sn-glycero-3-phospholipid + H2O = a 2-acyl-sn-glycero-3-phospholipid + a fatty acid + H+. Note that the substrate has a diacyl group attached to the glycerol group.
  • GO:0004623 A glycerophospholipase activity that cleaves the fatty acid attached to the sn-2 position of the glycerol group of a glycerophospholipid. Substrates include phosphatidylcholine, phosphatidylethanolamine, choline plasmalogen and phosphatides.
  • GO:0016042 The chemical reactions and pathways resulting in the breakdown of lipids, compounds soluble in an organic solvent but not, or sparingly, in an aqueous solvent.

Sequence domains and features

Domain and signature matches imported from InterPro and related databases.

34 records
Show feature table
Start End DB Term Name
37 285 SUPERFAMILY SSF56931 Outer membrane phospholipase A (OMPLA)
37 285 InterPro IPR036541 Phospholipase A1 superfamily
47 277 CDD cd00541 OMPLA
47 277 InterPro IPR003187 Phospholipase A1
41 282 Pfam PF02253 Phospholipase A1
41 282 InterPro IPR003187 Phospholipase A1
1 20 Phobius SIGNAL_PEPTIDE Signal peptide region
30 286 Gene3D G3DSA:2.40.230.10 Phospholipase A1
30 286 InterPro IPR036541 Phospholipase A1 superfamily
1 2 Phobius SIGNAL_PEPTIDE_N_REGION N-terminal region of a signal peptide.
24 286 PANTHER PTHR40457 PHOSPHOLIPASE A1
24 286 InterPro IPR003187 Phospholipase A1
153 167 PRINTS PR01486 Bacterial phospholipase A1 protein signature
153 167 InterPro IPR003187 Phospholipase A1
123 142 PRINTS PR01486 Bacterial phospholipase A1 protein signature
123 142 InterPro IPR003187 Phospholipase A1
233 250 PRINTS PR01486 Bacterial phospholipase A1 protein signature
233 250 InterPro IPR003187 Phospholipase A1
100 116 PRINTS PR01486 Bacterial phospholipase A1 protein signature
100 116 InterPro IPR003187 Phospholipase A1
200 218 PRINTS PR01486 Bacterial phospholipase A1 protein signature
200 218 InterPro IPR003187 Phospholipase A1
168 186 PRINTS PR01486 Bacterial phospholipase A1 protein signature
168 186 InterPro IPR003187 Phospholipase A1
255 275 PRINTS PR01486 Bacterial phospholipase A1 protein signature
255 275 InterPro IPR003187 Phospholipase A1
78 95 PRINTS PR01486 Bacterial phospholipase A1 protein signature
78 95 InterPro IPR003187 Phospholipase A1
30 286 FunFam G3DSA:2.40.230.10:FF:000001 Phospholipase A(1)
1 20 SignalP_GRAM_NEGATIVE SignalP-noTM SignalP-noTM
21 286 Phobius NON_CYTOPLASMIC_DOMAIN Region of a membrane-bound protein predicted to be outside the membrane, in the extracellular region.
15 20 Phobius SIGNAL_PEPTIDE_C_REGION C-terminal region of a signal peptide.
1 22 SignalP_GRAM_POSITIVE SignalP-TM SignalP-TM
3 14 Phobius SIGNAL_PEPTIDE_H_REGION Hydrophobic region of a signal peptide.

3D structure

Selected loaded structure. Experimental PDB entries may cover only a portion of the sequence; AlphaFold DB and ColabFold models typically cover the full protein but remain computational predictions.

Download VMD script Full viewer

Loading 3D structure...

Drag to rotate — click the view, then scroll to zoom.

Pocket score High Medium Low
How colors and pocket overlays are used
Uniform protein color marks the displayed model as a single molecular object.
Experimental PDB structures may be colored by chain to distinguish subunits or copies present in the file.
Pocket colors and alpha spheres are evidence overlays for predicted binding cavities; they are not alternative protein chains.
'Alpha spheres' is FPocket's own cavity-shape geometry, imported when available and aligned with the loaded structure.
'Pocket atoms'/'Predicted site atoms' show the pocket's residue atoms instead: P2Rank reports residues rather than alpha spheres, and FPocket falls back to this when alpha-sphere geometry is unavailable or doesn't align.
'No pocket geometry' means neither alpha spheres nor residue-position data could be found for that pocket; the layer just highlights the same residues as 'Nearby residues'.
Pocket details Inspect a specific pocket, or open the full viewer

Binding pockets · P2Rank

Druggability (P2Rank): high ≥ 0.5 · medium 0.2–0.49 · low < 0.2

Pocket 1 P2Rank #1
0.909
Show in viewer
Surrounding area
Pocket 2 P2Rank #2
0.041
Show in viewer
Surrounding area
Pocket 3 P2Rank #3
0.011
Show in viewer
Surrounding area
Pocket 4 P2Rank #4
0.008
Show in viewer
Surrounding area
Pocket 5 P2Rank #5
0.005
Show in viewer
Surrounding area

Binding pockets · FPocket

Druggability (FPocket): high ≥ 0.7 · medium 0.4–0.69 · low < 0.4

Pocket 1 FPocket #8
0.67
Show in viewer
Surrounding area
Pocket 2 FPocket #5
0.395
Show in viewer
Surrounding area
Pocket 3 FPocket #14
0.309
Show in viewer
Surrounding area
Residue sets
UniProt: Active site:159-159 Proton acceptor
UniProt: Active site:161-161 Nucleophile
UniProt: Binding site:123-123 in dimeric form
UniProt: Binding site:164-164 in dimeric form
UniProt: Binding site:169-169 in dimeric form
UniProt: Binding site:201-201 in dimeric form
All structural evidence 0 experimental · 2 predicted

Structural evidence

0 + 2

Experimental PDB entries plus predicted AlphaFold DB or ColabFold models. Click Switch to display a different loaded structure in the viewer.

Entry Method Resolution Chain Coverage Links Status
AlphaFold DB AF_A0A0H3GGK3
AlphaFold DB full sequence Viewing
ColabFold KP13_01718
ColabFold full sequence Loaded

Ligand evidence

Ligands grouped by evidence source. PDB ligands keep the source crystal visible, and loaded crystals can be opened directly in the structure viewer.

51 records
Chemistry signal

Structural ligand evidence is available for this target.

Direct evidence 0 same-protein records
Transferred evidence 1 records from similar proteins
Structural ligands 1 0 loaded crystals
Measured bioactivity 0 direct and transferred ChEMBL records
Proposed compounds 50 similarity-based ZINC candidates
Best available ligand signal
HDS PDB via homolog 306.5 Da · LogP 5.36 · TPSA 54.4 Open detail RCSB PDB
ZINC100019805 ZINC proposed compound · Tanimoto 1.000 Detail ZINC
ZINC1625794 ZINC proposed compound · Tanimoto 1.000 Detail ZINC
ZINC1651926 ZINC proposed compound · Tanimoto 1.000 Detail ZINC
ZINC1843748 ZINC proposed compound · Tanimoto 1.000 Detail ZINC

Structural evidence inferred from similar proteins. The source crystal indicates where the ligand was observed; the UniProt column identifies the homologous protein carrying that ligand.

Show only:
Ligand Source crystal UniProt (homolog) MW · LogP · TPSA Lipinski PAINS SMILES
HDS RCSB PDB P0A921 306.5 Da LogP 5.36 TPSA 54.4 1 viol. ✓ Clean CCCCCCCCCCCCCCCCS(=O)(=O)O

PDB and ChEMBL records on this protein are shown in full. ChEMBL records from similar proteins are capped at the top 100 per protein (by pchembl) and ZINC at the top 50 (Tanimoto ≥ 0.5). ADME columns are descriptor-based screening flags, not experimental toxicity results.

Cross-references

External database identifiers for this protein, its structures, ligands, and metabolic reactions.